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Abstract
Introduction With the increasing use of neuroimaging stud-
ies, the discovery of incidental neoplastic lesions is becoming
more frequent. However, standard procedures are lacking,
and little is known about their optimal management.
Case Report We here present the case of a boy with a cere-
bellar mass incidentally discovered on a CT scan performed
after head trauma. In another scan performed after another
incident of head trauma 14 months earlier, the lesion could be
seen after retrospective examination. In view of the asymp-
tomatic clinical and stable radiological status and the pre-
sumed diagnosis of a low-grade glioma, a watch-and-wait
strategy was elected. After clinical and radiological progres-
sion was observed, the tumour was resected, 2½years after
the initial imaging study. Histological evaluation revealed a
WNT pathway-activated classical medulloblastoma.
Discussion To our knowledge, this is the first description of
such a long natural history and pre-symptomatic period of a
medulloblastoma. The long period of stability followed by a
period of accelerated tumour growth is compatible with
increasing biological aggressiveness, possibly related to
the stepwise accumulation of genetic changes.
Keywords Medulloblastoma . Brain neoplasms . Incidental
findings . Child . Cancer . Radiology
Introduction
Due to increasing use of neuroimaging studies, the number
of neoplastic incidentalomas, i.e. incidentally discovered
abnormal findings unrelated to the purpose of the examina-
tion, has been rising, with an overall prevalence ranging
from 0.1 to 1 % [13, 16]. After the detection of a lesion,
standard procedures are lacking, and little is known about
the optimal management. In many instances, the neuroim-
aging features are not diagnostic, and histopathologic diag-
nosis comprises a diverse spectrum of entities. Here, we
present the case of a boy with a cerebellar incidentaloma,
which was resected after 2½years of observation and, sur-
prisingly, yielded the diagnosis of medulloblastoma (MB).
Case report
After sustaining a minimal head trauma in April 2006, a 6½-
year-old boy underwent a cranial CT scan in another insti-
tution, which at that time was judged as normal. Fourteen
months later, during the investigation of a similar head
trauma, another CT scan was performed, which showed a
circumscribed, mainly hyperdense vermian mass with a
diameter of 2 cm without any evidence of obstructive
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hydrocephalus (Fig. 1). Retrospectively, the identical find-
ing was identified on the first scan. The patient was then
referred to our institution for neuropaediatric evaluation,
where a MRI showed an inhomogenously contrast enhanc-
ing lesion without perifocal oedema with an inhomogeneous
hypo- and hyperintense signal in T2 and FLAIR sequences,
and a larger proportion showing no diffusion restriction with
a correspondingly elevated ADC value. The patient
complained of headache, tiredness and dizziness, which
could not be explained by the lesion, and which subsequent-
ly resolved spontaneously. The neurological examination
was normal. Since the presumptive diagnosis was a low-
grade glioma, a wait-and-see strategy was chosen. A follow-
up MRI in December 2007 showed discrete signs of pro-
gression, with increased contrast enhancement and exten-
sion of the tumour into the right foramen of Luschka and left
cerebellar grey matter. Despite radiographic evidence of
progression, the patient remained asymptomatic. An MRI
performed 4 months later was unchanged when compared to
the previous MRI. At that time, the patient complained of
blurred vision, loss of balance and coordination deficits. On
neurological examination, moderate truncal ataxia, bilateral
dysmetria, right-sided dysdiadochokinesis, and nystagmus
were noted. In addition, right monocular double vision and
visual acuity that fluctuated between 0.3 and normal were
documented; however, not all of the findings could be
explained by the tumour. Clinically, fatigue and gait distur-
bance persisted, and a subsequent MRI in December 2008
showed further tumour progression. Accordingly, the tu-
mour was partially resected in January 2009, with the his-
tological diagnosis of a classical MB (Fig. 2). The MIB-1
proliferation index was 10 %, and more than 10 % of tumour
cells showed strong nuclear immunoreactivity for beta-
catenin. A CTNNB1 mutation (S37P) was found, corre-
sponding to medulloblastoma of the WNT subgroup [15].
Immunohistochemical analyses for hedgehog target genes
as well as genomic and immunohistochemical analyses for
c-myc amplification and target genes were negative. There
was no evidence of micro- or macroscopic CNS metastases.
The patient received craniospinal radiotherapy with con-
comitant vincristine followed by eight chemotherapy cycles
with cisplatin, lomustine, and vincristine, and has stable
residual disease for more than 3 years.
Fig. 1 a–f Serial images
illustrating the natural growth
behaviour with a prolonged
period of stability followed by
progression of a
medulloblastoma initially
discovered as an incidentaloma
(arrow). a CT scan,
April 2006; b CT scan, June
2007 (stable disease);
c MRI (T2), July 2007
(stable disease); d MRI (T2),
December 2007 (progressive
disease); e MRI (T2),
April 2008 (stable disease
compared to 1D);
f MRI (T2), December 2008
(progressive disease)
Fig. 2 Medulloblastoma: cerebellar cortex infiltrated by densely
packed monomorphous tumour cells with moderate nuclear pleomor-
phism and scant cytoplasm
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Discussion
To our knowledge, this is the first description of such a long
natural history and pre-symptomatic period in a patient with
an untreated MB that was incidentally discovered on imag-
ing. Due to the incidental nature of its discovery, the stable
size during the 14-month interval between the first and the
second CT scan and the lack of neurological signs or symp-
toms (and despite an unequivocal hyperdensity on
unenhanced CT, which is suspicious for a tumour with in-
creased cellular density), the working diagnosis was low-
grade glioma, which prompted a wait-and-see approach.
Surgery was only performed after clear clinical and radiolog-
ical progression, altogether 2½years after the first CT scan.
In most instances, the appearance of neurological symp-
toms precedes the radiological diagnosis of a posterior fossa
tumour, followed by immediate surgical extirpation. There-
fore, in contrast to the reported case, the kinetics of tumour
growth before the appearance of the first symptom(s) are
unknown. Accordingly, only the length of the prediagnostic
symptomatic interval (PSI) can provide some indirect evi-
dence regarding the kinetics of tumour growth: Not only are
differences documented between different types of brain
tumours, with malignant tumours (e.g. MBs) having shorter
PSIs than low-grade tumours [4, 10, 12, 17, 19], but con-
siderable variability is seen within the patient group with
MB [2, 8]: In a large prospective series, we found PSIs
ranging from 0 to 24 months, with a median of 2 months.
Interestingly, the group of patients with the longest PSIs had
lower-stage disease at diagnosis and a better overall survival
probability than that with shorter PSIs [6]. The likely expla-
nation for these results probably lies in the broad spectrum
of biologic behaviour within the whole group of MB [3, 15].
The present tumour can be classified histologically as WNT
pathway-activated MB. This MB subtype is associated with
a favourable prognosis [5, 15]. One could speculate that the
tumour acquired a stepwise accumulation of genetic aberra-
tions over time, which—after a relatively stable phase—
resulted in accelerated growth. This hypothesis is consistent
with the findings of an accumulation of such aberrations in
relapsed medulloblastoma when compared to their corre-
sponding primary tumours [9].
Due to the more frequent use of neuroradiologic imaging,
the number of neoplastic incidentalomas has been steadily
rising [13, 16]. While for a definitive histological diagnosis
of a posterior fossa tumour a neuropathological examination
is needed, neuroimaging can offer a certain diagnostic guid-
ance, notably regarding the distinction between a high and a
low cellularity. In the case of this patient, due to the long-
lasting constant size and the lack of clinical symptoms, a
low-grade tumour was suspected, even if on the basis of the
increased CT density this working diagnosis would have to
be doubted. Low-grade gliomas are tumours with a low
cellularity and therefore exhibit low CT density values
[11], while the typical CT appearance of medulloblastoma
is hyperdense before contrast medium application [14, 18].
CT density still remains a very good tool to differentiate
between lesions with low and high cellular density [1]. In
magnetic resonance imaging, comparison of apparent diffu-
sion coefficient parameters revealed distinctive values in
different entities of posterior fossa tumours in single-centre
reports [7, 20].
Conclusion
This is the first description of MB with such a long natural
history diagnosed as an incidentaloma that was followed
according to a wait-and-see approach. During the long pe-
riod of clinical and radiological stability preceding the ra-
diological and clinical progression, the working diagnosis
was low-grade glioma, despite a nonfitting hyperdensity of
the tumour on CT. We suspect an accumulation of genetic
aberrations over time leading to a change of growth behav-
iour. However, as the tumour was not biopsied at the time of
radiological detection, this remains speculative.
There are no evidence-based guidelines for the manage-
ment of neoplastic CNS incidentalomas. Not only a precise
histological diagnosis can often not be made on radiological
grounds, but also a neoplastic incidentaloma might clinical-
ly behave differently compared to a lesion of the same
histology diagnosed on the basis of symptoms. Whereas a
delay in treatment in some patients may have negative
consequences, unnecessary surgical exploration may also
be associated with considerable morbidity (e.g. CNS le-
sions, haemorrhage). Therefore, a case-by-case evaluation
by an interdisciplinary tumour board is recommended, with
the consideration of parameters such as the radiological
nature of the lesion, the differential diagnosis, the evolution
and the clinical state of the patient.
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